Insulin-secreting pancreatic islet cells have been generated from human spermatogonial stem cells (SSCs) directly isolated from human testicular tissue, researchers reported today at the American Association of Cell Biology 50th Annual Meeting in Philadelphia.
When grafted into diabetic mice that lacked a transplant-rejecting immune system, the bioengineered cells functioned much like somatic â-islet cells, the Georgetown University (GU) Medical Center researchers said.
By decreasing the animals' blood glucose levels, the human-derived islet cells demonstrated their potential to counter diabetic hyperglycemia in humans, added G. Ian Gallicano, Ph.D., who heads the GU research team.
Gallicano said that these results represent the first step of a transplant strategy to deliver â-islet cells that would not be rejected by the patient with type 1 diabetes because the stem cells would be obtained from the patient's own SSCs, the earliest precursors of male gamete sperm cells.
This transplant strategy would avoid the host-versus-graft issues that have plagued other transplant treatments for type 1 diabetes, Gallicano explained, because the SSCs would be obtained from male patients, modified in the laboratory to secrete insulin, and transplanted back to the donors.
Although surgeons currently transplant islet tissue from deceased donors into female and male patients with type 1 diabetes, this therapy is hampered by a woeful shortage of suitable donations and by complications resulting from host-versus-graft disease.
Gallicano said that obtaining beta-islet-like cells from the male patient's SSCs could solve the problem of immune rejection in males with type 1 diabetes, since the "treatment based on this research would be 'autologous,' that is, the cells come from the patient and would be recognized as 'self.'"
The fundamental approach of transforming male gametes into pluripotent stem cells might also be applicable to the female counterpart, oocytes, he added.
The â-islet-like cells were engineered from germ-derived pluripotent stem (gPS) cells produced from the SSCs. The engineered â-islet cells secreted insulin and exhibited many of the markers characteristic of normal islet cells including C-peptide (pro-insulin) production and the expression of PDX1, a transcription factor involved in pancreatic development.
For more information:
ASCB contacts:Cathy Yarbrough
Anirudh Saraswathula(1); Shenglin Chen, Asif Zakaria, and G. Ian Gallicano(2)1Biotechnology and Life Sciences Laboratory, Science and Technology Division, Thomas Jefferson High School for Science and Technology, Alexandria, VA.
2Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC
Cathy Yarbrough | EurekAlert!
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences